ParcelBio
Facts
as of Nov 19, 2026Elevated mRNA for transformative medicines. mRNA has already changed medicine. But the next generation of mRNA medicines – therapies that reprogram the immune system, kill tumors, and replace missing proteins – require a step-change in potency and durability. Conventional mRNA can't get there.
- Headquarters
- San Francisco, United States
- Employees
- 11-50estimated range
- Website
- parcelbio.com
These are the key facts about ParcelBio on Alion as of Nov 19, 2026. ParcelBio is headquartered in San Francisco, United States. The latest round is Seed of $13M, announced in 2026.
What the registers and the postings say about this employer.
Footprint
Hiring in 1 city in 1 country.
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| San Francisco United States | Headquarters | 0 |
Financials
Funding rounds, investors and revenue on record.
Money
ParcelBio has $13M paid in by investors, lenders and donors.
Owners & entities
Sources name SurgePoint Capital, General Catalyst, Metaplanet among the owners or investors of ParcelBio.
